In many centers internationally, current standard of care is to excise all papillomas of the
breast, despite recently reported low rates of upgrade to malignancy on final excision. The …

Papillomas of the breast are benign epithelial neoplasms. Because of the low, but continued
potential for malignancy, the treatment options after initial diagnosis remain controversial …

Background Papillary lesions of the breast are a relatively rare, but heterogeneous group
ranging from benign to atypical and malignant. Debate exists regarding the optimal …

Intraductal papilloma falls under the category of benign breast mass. However, recent
studies show that it can harbor occult carcinoma. The management of benign intraductal …

Background To determine whether patients with benign papilloma diagnosed on core
biopsy can be spared from surgery. Methods We prospectively reviewed 150 consecutive …

Background The management of intraductal papillomas on core biopsy continues to be
controversial. Papillomas with atypia are typically excised. However, it is unclear whether …

Abstract Evaluation of radiologically detected breast lesions is a common task in surgical
pathology. Some benign lesions on biopsy are associated with an upgrade to in situ or …

Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …

Papillary lesions of the breast range from benign to atypical to malignant. Although
papillomas without frank cancer are benign, their management remains controversial. When …

We investigate the clinical history, past medical history, and risk status in women with benign
intraductal papillomas (IDP). We observed an upgrade rate of 3.9% to ductal carcinoma in …